GI Cancer Institute

About

Since 1991, we have been committed to changing outcomes for people with gastro-intestinal (GI) cancer. Our key priority is to undertake research to improve patient care and medical practice. The 72 clinical trials conducted by the AGITG, since the group was first formed as a network of investigators, have involved over 7,000 participants treated at 124 sites in Australia, 8 sites in New Zealand and 110 sites located across Asia, Europe, North America and the Middle East.